Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.4157
-0.0350 (-7.77%)
At close: Mar 28, 2025, 4:00 PM
0.4300
+0.0143 (3.44%)
After-hours: Mar 28, 2025, 7:20 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $25.76 million as of March 28, 2025. Its market cap has decreased by -55.87% in one year.
Market Cap
25.76M
Enterprise Value
1.57M
1-Year Change
-55.87%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $25.76M, a decrease of -89.95%. That is a compound annual growth rate of -48.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 25.76M | -11.58% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |